2 results
Approved WMORecruiting
This study tests the ability of the Cue-shoe, a new cueing device, to provide patients with FoG with successful cueing.
Approved WMORecruiting
Phase 2:Primary ObjectivesTo determine the recommended Phase3 dose of mitapivat by evaluating the effect of 2 dose levels of mitapivat versus placebo on:• Anemia in subjects with sickle cell disease (SCD)• SafetySecondary ObjectivesTo evaluate the…